BioCentury
ARTICLE | Clinical News

CEP-1347: Started Phase II-II

August 5, 2002 7:00 AM UTC

Cephalon Inc. (CEPH),West Chester, Penn. H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Product: CEP-1347 Business: Neurological Therapeutic category: Neuroprotectant Target: Kinases Description: Mix...